However, recent evidence opposing this view has emerged, suggesting that SAgs (i.e., SEB) could expand influenza-specific CD8+ T cells when administered in vivo in mice, prior to virus infection, can re-organize the hierarchical pattern of primary CD8+ T cell responses, and promote improved recall immunity [272]. The gene discussed is CD8A; the disease is viral infectious disease.